Gestodene Production Cost Reports

The report provides a detailed analysis essential for establishing a Gestodene production plant. It encompasses all critical aspects necessary for Gestodene production, including the cost of Gestodene production, Gestodene plant cost, Gestodene production costs, and the overall Gestodene production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Gestodene production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Gestodene is a third-generation synthetic progestin, utilised in pharmaceutical formulations for hormonal contraception and related therapies. It functions as an active ingredient in combined oral contraceptives (COCs) like those paired with ethinylestradiol. It offers high potency in ovulation inhibition at low doses (e.g., 75 mcg), favourable cycle control with reduced bleeding or spotting, and minimal impact on lipid or carbohydrate metabolism compared to earlier progestins. Additionally, it has a potential role as a positive allosteric modulator of protease-activated receptor 1 (PAR1) to enhance platelet aggregation and thrombosis risk.

The market growth for Gestodene is driven by rising demand for effective hormonal contraception and focus on women’s reproductive health across both developed and emerging markets, with combined oestrogen–progestin oral contraceptives remaining a major revenue segment. Increasing awareness of family planning, supportive government and NGO initiatives, and improving access to healthcare services and reimbursement in many countries further stimulate uptake of gestodene-containing products.

The introduction of new low-dose and combination formulations, along with advanced delivery systems that enhance compliance, aligning with patient and prescriber preference for high-efficacy, convenient contraceptives, boosts the market growth. Additionally, the expanding global hormonal contraception and female contraceptive markets provide a favourable demand environment for gestodene-based products. Industrial gestodene procurement is influenced by pricing volatility from low-dose formulation demands (50-75 mcg per tablet), raw material sourcing costs for its ethinylestradiol combinations, and batch-specific purity requirements (≥98-99% HPLC).

Raw Material for Gestodene Production

According to the Gestodene production plant project report, the raw material for Gestodene production includes 18 methyl 4 estren 3,17 dione.

Production Process of Gestodene

The extensive Gestodene production cost report consists of the following major industrial production process:

1. Production via chemical synthesis: The production process of gestodene starts from 18 methyl 4 estren 3,17 dione, in which the 3 keto function is first protected as a cyclic ketal (e.g., with 2,2 dimethyl 1,3 propanediol under acid catalysis in dichloromethane), giving a 3 ketal/17 ketone intermediate that tolerates subsequent base mediated transformations. In the first step, the 16 position is functionalised under basic conditions to install a phenylsulfoxide (or related sulfinyl/sulfonyl group) alpha to the 17 ketone, via sulfenylation or sulfinylation of the protected ketone. The reaction is followed by oxidation to the sulfoxide as a diastereomeric mixture. Thermolysis or base assisted elimination of the 16 phenylsulfoxide in a high boiling solvent such as xylene, often in the presence of triethylamine, effects a syn elimination to form the desired 15,16 double bond, yielding a D ring enone intermediate. The 17α ethynyl group is introduced by nucleophilic addition of a lithium acetylide complex (e.g., lithium acetylide–ethylenediamine in THF) to the 17 keto group, giving a 17 ethynyl 17β hydroxy derivative while the 3 ketal remains intact. Final deprotection of the 3 ketal under acidic conditions regenerates the 3 keto function, producing gestodene as the final product.

Properties of Gestodene

Gestodene (C21H26O2, molecular weight 310.43) appears as a white to off-white crystalline powder or solid with high purity requirements (≥98-99% by HPLC) for API use. It has a melting point in the range of 190-192 degree Celsius, an estimated density of 1.15±0.1 g/cm³, and has a boiling point around 462.7±45.0 degree Celsius. It has low water solubility but good solubility in DMSO (>20 mg/mL) and organic solvents like dichloromethane, aiding its formulation and processing. It has a specific optical rotation of [α]/D -175 to -195° (in DCM), a pKa of 12.16±0.40 indicative of its 17β-hydroxy group, and stability under sealed, dry, frozen storage (< -20 degree Celsius) to prevent degradation. Its steroid structure includes a Δ15,16 double bond and 17α-ethynyl group, conferring potent progestogenic selectivity.